Literature DB >> 24788405

Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice.

John M Starbuck1, Tara Dutka2, Tabetha S Ratliff2, Roger H Reeves2, Joan T Richtsmeier1,3.   

Abstract

Trisomy 21 results in gene-dosage imbalance during embryogenesis and throughout life, ultimately causing multiple anomalies that contribute to the clinical manifestations of Down syndrome. Down syndrome is associated with manifestations of variable severity (e.g., heart anomalies, reduced growth, dental anomalies, shortened life-span). Craniofacial dysmorphology and cognitive dysfunction are consistently observed in all people with Down syndrome. Mouse models are useful for studying the effects of gene-dosage imbalance on development. We investigated quantitative changes in the skull and brain of the Dp(16)1Yey Down syndrome mouse model and compared these mice to Ts65Dn and Ts1Cje mouse models. Three-dimensional micro-computed tomography images of Dp(16)1Yey and euploid mouse crania were morphometrically evaluated. Cerebellar cross-sectional area, Purkinje cell linear density, and granule cell density were evaluated relative to euploid littermates. Skulls of Dp(16)1Yey and Ts65Dn mice displayed similar changes in craniofacial morphology relative to their respective euploid littermates. Trisomy-based differences in brain morphology were also similar in Dp(16)1Yey and Ts65Dn mice. These results validate examination of the genetic basis for craniofacial and brain phenotypes in Dp(16)1Yey mice and suggest that they, like Ts65Dn mice, are valuable tools for modeling the effects of trisomy 21 on development.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Down syndrome; brain morphology; craniofacial morphogenesis; gene-dosage imbalance; trisomy 21

Mesh:

Year:  2014        PMID: 24788405      PMCID: PMC4107150          DOI: 10.1002/ajmg.a.36594

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  39 in total

1.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

Authors:  Bruce F Pennington; Jennifer Moon; Jamie Edgin; Jennifer Stedron; Lynn Nadel
Journal:  Child Dev       Date:  2003 Jan-Feb

2.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

Authors:  Laura G Reinholdt; Yueming Ding; Griffith J Gilbert; Griffith T Gilbert; Anne Czechanski; Jeffrey P Solzak; Randall J Roper; Mark T Johnson; Leah Rae Donahue; Cathleen Lutz; Muriel T Davisson
Journal:  Mamm Genome       Date:  2011-09-28       Impact factor: 2.957

3.  Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

Authors:  J T Richtsmeier; L L Baxter; R H Reeves
Journal:  Dev Dyn       Date:  2000-02       Impact factor: 3.780

4.  Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.

Authors:  Joan T Richtsmeier; Ann Zumwalt; Elaine J Carlson; Charles J Epstein; Roger H Reeves
Journal:  Am J Med Genet       Date:  2002-02-01

5.  The palate and Down's syndrome.

Authors:  B L Shapiro; R J Gorlin; R S Redman; H H Bruhl
Journal:  N Engl J Med       Date:  1967-06-29       Impact factor: 91.245

6.  Craniofacial complex in the trisomy 21 syndrome (Down's syndrome).

Authors:  W A Frostad; J F Cleall; L C Melosky
Journal:  Arch Oral Biol       Date:  1971-07       Impact factor: 2.633

7.  Age and gender effects on microglia and astrocyte numbers in brains of mice.

Authors:  Peter R Mouton; Jeffrey M Long; De-Liang Lei; Victor Howard; Mathias Jucker; Michael E Calhoun; Donald K Ingram
Journal:  Brain Res       Date:  2002-11-22       Impact factor: 3.252

8.  Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.

Authors:  L E Olson; R J Roper; L L Baxter; E J Carlson; C J Epstein; R H Reeves
Journal:  Dev Dyn       Date:  2004-07       Impact factor: 3.780

9.  Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions.

Authors:  Katheleen Gardiner; Andrew Fortna; Lawrence Bechtel; Muriel T Davisson
Journal:  Gene       Date:  2003-10-30       Impact factor: 3.688

Review 10.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

View more
  22 in total

1.  The Influence of trisomy 21 on facial form and variability.

Authors:  John M Starbuck; Theodore M Cole; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

2.  Early impacts of modified food consistency on oromotor outcomes in mouse models of Down syndrome.

Authors:  Tiffany J Glass; Sara L Twadell; Luke C Valmadrid; Nadine P Connor
Journal:  Physiol Behav       Date:  2018-11-26

Review 3.  Influence of allelic differences in Down syndrome.

Authors:  Randall J Roper; Laura Hawley; Charles R Goodlett
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

Review 4.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

5.  Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.

Authors:  Joseph W Goodliffe; Jose Luis Olmos-Serrano; Nadine M Aziz; Jeroen L A Pennings; Faycal Guedj; Diana W Bianchi; Tarik F Haydar
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

Review 6.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 7.  Mouse-based genetic modeling and analysis of Down syndrome.

Authors:  Zhuo Xing; Yichen Li; Annie Pao; Abigail S Bennett; Benjamin Tycko; William C Mobley; Y Eugene Yu
Journal:  Br Med Bull       Date:  2016-10-27       Impact factor: 4.291

8.  Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.

Authors:  Samantha D McElyea; John M Starbuck; Danika M Tumbleson-Brink; Emily Harrington; Joshua D Blazek; Ahmed Ghoneima; Katherine Kula; Randall J Roper
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

9.  Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice.

Authors:  Tara Dutka; Dorothy Hallberg; Roger H Reeves
Journal:  Mech Dev       Date:  2014-12-12       Impact factor: 1.882

10.  Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier.

Authors:  Huiqing Li; Sarah Edie; Donna Klinedinst; Jun Seop Jeong; Seth Blackshaw; Cheryl L Maslen; Roger H Reeves
Journal:  Genetics       Date:  2016-03-30       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.